The Compassionate Intervention Act creates a statutory framework for involuntary intervention aimed at people whose severe substance use or addiction makes them likely to cause substantial harm to themselves or others. It sets up a new administrative body (the Compassionate Intervention Commission), statutory and medical directors, designated supervisors, and a system of designated facilities and community providers to apprehend, assess and, where authorized, place clients into secure or community‑based treatment.
For administrators, clinicians, police and privacy officers this is a major operational and legal change. The Act reallocates responsibilities across health and justice actors, lowers barriers to cross‑sector information sharing for assessment and oversight, and establishes quick tribunal processes and fixed maximum orders — decisions that will hinge on bed availability, treatment capacity and forthcoming regulations that define many operational details.
At a Glance
What It Does
The Act authorizes third‑party applications to a provincial Commission to obtain orders that allow police to apprehend and convey people for short‑term medical stabilization and assessment, and for a tribunal to issue care plans that can require secure inpatient or community‑based treatment. It creates the Commission and senior roles (statutory and medical directors) to manage reviews, designate facilities and oversee treatment teams.
Who It Affects
Directly affected parties include regulated health professionals and family members who may apply, police and peace officers asked to apprehend and convey, compassionate intervention facilities and community‑based providers required to accept clients and report incidents, and privacy custodians who must produce records when ordered. Provincial health agencies and legal counsel will be drawn into oversight, appeals and compliance work.
Why It Matters
This statute establishes an administrative route for involuntary addiction care rather than traditional criminal or mental‑health involuntary admission models, with explicit privacy exceptions and expedited hearing timelines; it therefore alters thresholds for deprivation of liberty, creates new reporting burdens, and concentrates decision‑making in an administrative tribunal backed by clinical direction.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The Act creates a statutory pathway for early stabilization and treatment when severe substance use or addiction makes a person likely to cause substantial harm. Qualified applicants — limited to family members, certain regulated care providers and police/peace officers — submit an application to a statutory director.
The statutory director screens the application and forwards eligible matters to a lawyer member of the newly formed Compassionate Intervention Commission, who decides whether there are sufficient grounds, on a balance of probabilities, to issue an apprehension order (authorizing police to detain and convey) and an assessment order (authorizing short‑term admission for medical assessment).
Once a person is brought to a designated facility, the treatment team must complete a substance‑use and addiction assessment and produce a written assessment report to the medical director and statutory director within 48 hours where possible; that triggers a care plan hearing. The Commission convenes a three‑member hearing panel (lawyer, physician, public member) to decide, again on a balance of probabilities, whether a care plan order is needed.
If issued, a care plan directs either secure inpatient treatment or community‑based treatment (bed‑based or non‑bed‑based) and specifies authorities and rights. Secure orders may last up to three months and community‑based orders up to six months, with statutory renewal and review mechanisms.The Act layers administrative safeguards: early discharge applications, periodic mandatory review hearings at set intervals, non‑compliance reviews if clients abscond or fail to engage, and an appeals process within the Commission culminating in a final administrative decision subject to judicial review.
It also creates an expanded information‑sharing regime: applicants and health actors may disclose or be required to produce identifying health and personal information without consent for the purposes of applications, hearings, oversight and monitoring. Finally, the Act delegates operational detail to regulations (designation criteria, reporting standards, leave authorities, drug administration rules), so many day‑to‑day obligations will be specified after proclamation.
The Five Things You Need to Know
Only family members, specified regulated health professionals, addiction counsellors and police/peace officers may apply for an assessment order; no private citizens may apply.
A lawyer member of the Compassionate Intervention Commission makes the first legal determination and, if satisfied on a balance of probabilities, the Commission issues both an apprehension order (police authority to detain) and an assessment order (short‑term medical admission).
Treatment teams must complete a substance use and addiction assessment and submit an assessment report within 48 hours of apprehension or admission, triggering a care plan hearing.
A care plan hearing panel (lawyer chair, physician and public member) must be convened and ordinarily decide within set short timelines; secure care plan orders last up to 3 months, community‑based orders up to 6 months, both renewable under statutory review rules.
The Act creates broad exceptions to consent and privacy rules: applicants and several authorities may collect and disclose identifying health and personal information without client consent for application, oversight, reporting and judicial review purposes.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Who qualifies and the harm threshold
These sections set the substantive threshold for intervention: an order can issue only if the person is “likely to cause harm” due to substance use or addiction. The statute lists factors to be weighed for adults (overdose history, deterioration, inability to meet daily needs, high‑risk behaviour) and minors (age, substance, school impacts, recent child‑welfare involvement). Severity is operationalized by clinical markers (patterned severe intoxication, unstable medical conditions, inability to meet basic needs). Practically, these provisions push decision‑making toward clinical judgment informed by objective indicators, but they leave significant discretion to the Commission and to regulations to define how factors are measured.
Compassionate Intervention Commission and procedures
The Act establishes a dedicated administrative tribunal composed of lawyer, physician and public members. The Commission’s powers include receiving applications, issuing or terminating orders, conducting non‑compliance reviews and appeals, and compelling information from public bodies or custodians. Procedural rules, quorum and eligibility for panel service are delegated to regulation, so the Commission’s day‑to‑day operations will depend heavily on regulatory design (member selection, conflict rules, remuneration and procedural fairness protocols).
Statutory director, medical director and designated supervisors
Two senior executive roles split screening, clinical oversight and delegated supervision. The statutory director (a public‑service appointee) screens applications and handles records; the medical director (appointed by the provincial health agency) sets binding clinical policies for treatment teams, can review and direct team decisions, and oversees clinical documentation standards. Community providers must name a designated supervisor responsible for compliance, reporting progress and non‑compliance. These provisions centralize clinical governance and create formal reporting lines between health administration and the tribunal.
Designation of facilities, service providers and treatment teams
The Minister may designate specific facilities for compassionate intervention (adult or minor), and designate bed‑based and non‑bed community providers. Facilities must report serious incidents and adhere to regulatory oversight. The medical director creates treatment teams on admission; when a client moves to community care the designated supervisor forms the receiving team. In practice, the Act ties legal authority to licensed providers and creates a continuing obligation to maintain beds, staffing and reporting systems to operate the scheme.
Application pathway and the Commission’s screening role
Applicants must complete a Ministerial pre‑application information session and submit forms, health reports (when a regulated professional is the applicant) or detailed police reports. The statutory director performs an eligibility and completeness screen and may defer assessment reviews for bed shortages or special circumstances. A lawyer member then reviews the substantive materials and, on a balance of probabilities, either issues apprehension and assessment orders or dismisses the application with written reasons. The structure front‑loads legal review before any detention occurs, but authorizes swift police action once an order is issued.
Powers on apprehension, assessment and immediate care
An apprehension order authorizes police to detain using reasonable force and to convey a person to a designated facility; the assessment order authorizes admission and allows the medical director to detain the client for an initial assessment period (notably the Act contemplates up to 72 hours for detention to enable assessment). Treatment teams must stabilize the person, perform a substance use and addiction assessment, and submit an assessment report that evaluates likelihood of harm and treatment recommendations. These provisions integrate police transport, emergency stabilization and rapid clinical assessment into one statutory flow.
Care plan hearings, orders, reviews and renewals
Within the statutory scheme, a three‑member hearing panel decides whether a care plan order is necessary and which level of restrictiveness is required. Panels must weigh least‑restrictive options, and may issue secure inpatient orders or community‑based orders (bed‑based or non‑bed‑based). The Act prescribes review intervals, mandatory progress reporting prior to reviews, non‑compliance review procedures when clients abscond or fail to engage, and renewal limits (secure orders renew in shorter increments than community orders). These mechanics create a predictable cadence of oversight but rely on timely access to reviews and on sufficient treatment capacity.
Discharge, appeals and evidentiary framework
Discharge applications may be brought by treatment teams and reviewed by a lawyer member of the Commission; clients and guardians have appeal rights within the Commission and the tribunal’s decisions are final subject to judicial review. Panels are not bound by judicial rules of evidence and may record and retain proceedings as specified in regulation. The evidentiary and appellate design favors administrative flexibility and speed, but places a premium on robust written reasons and accessible recordings for later review.
Consent, privacy, oversight and regulatory architecture
The Act carves out limited rights to refuse certain categories of care (observation, monitoring, clinical advice and, if authorized, administration of specified drugs) and establishes an expansive set of privacy exceptions permitting disclosure of health and personal information without client consent for applications, oversight and monitoring. The Minister gets broad inspection and enforcement powers, including warrantless entry to non‑private premises. Almost all operational detail (designations, reporting content, leave authorities, drug administration rules, and appeals roster governance) is left to regulation — meaning implementation will hinge on the forthcoming regulatory package and resource allocations.
This bill is one of many.
Codify tracks hundreds of bills on this topic across all five countries.
Explore this topic in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- People with severe, destabilizing substance use who previously declined or couldn’t access timely care — the statute creates a legally backed pathway for rapid stabilization, assessment and arranged post‑discharge planning. This is intended to reduce immediate medical risk and connect people to treatment they might not otherwise accept.
- Family members and some front‑line clinicians — the Act authorizes them to initiate applications and participate through impact statements and involvement in hearings, giving them a formal role when someone’s substance use creates acute harms.
- The Mental Health Patient Advocate — the office is given explicit powers to obtain information, investigate complaints about facilities or providers, and produce public reporting, strengthening a statutory ombudsperson role in this new regime.
- Designated community providers and specialized facilities — once funded and licensed under the regime, these providers gain statutory authority to receive clients and deliver care with legal backing for conveyance and enforcement. They also receive clearer clinical direction through the medical director’s policies.
- Provincial system planners — the Act consolidates administrative oversight and reporting mechanisms, which, if resourced, could improve data collection, system monitoring and targeted investments in addiction services.
Who Bears the Cost
- Police and peace officers — the statute requires police authority to apprehend, re‑apprehend and convey clients and to take reasonable force; implementation increases operational demands, training needs and potential liability exposure.
- Compassionate intervention facility service providers and community‑based service providers — they must meet designation standards, accept involuntary admissions or community‑based clients, prepare reports, accept ministerial inspections and comply with new rules — all of which will increase staffing, clinical governance and documentation costs.
- Health information custodians and privacy officers — broad, consent‑bypassing disclosure rules and Commission production orders will require new policies, legal reviews and potentially increased FOIP/HIA handling; custodians will need clarity from regulations to avoid breaches.
- The provincial health agency and Minister’s department — the Act centralizes oversight and creates numerous delegated powers (medical director, statutory director, inspections, reporting) that will require funding and administrative capacity to fulfill.
- Clients — the statute authorizes detaining people and delivering certain treatments without consent in prescribed circumstances, introducing real costs to individual liberty and the risk of coercive care that will require careful safeguards.
Key Issues
The Core Tension
The central dilemma the Act addresses is legitimate and stark: how to enable timely, clinically directed interventions to prevent imminent harm from severe substance use while protecting autonomy and procedural fairness. The law privileges speed and administrative flexibility—lowering the evidentiary threshold and widening information sharing—to get people quickly into care, but those same features concentrate discretionary power and risk coerced treatment without the fuller judicial safeguards that traditionally accompany liberty‑depriving orders.
The Act trades immediacy for administrative discretion. It authorizes relatively quick, administrative deprivation of liberty based on a balance‑of‑probabilities standard and a list of clinical and behavioural factors rather than the higher criminal or some mental‑health involuntary admission standards.
That expediency is intentional for timely stabilization, but it raises questions about whether written reasons, recordings and short appeal windows will be sufficient procedural protections for people deprived of liberty. The reliance on lawyer members for initial screening concentrates legal gatekeeping in a single role; how conflicts, recusal and member eligibility are handled in regulation will materially affect fairness.
Operationally, the Act hinges on capacity. Multiple provisions permit deferral of reviews and screening based on bed availability; designating facilities and providers and ensuring 24/7 conveyance capacity are prerequisites to the Act functioning as intended.
If beds are scarce, applications will be deferred or rejected and police and applicants will face practical dead ends — shifting the burden back onto emergency services. The broad privacy carve‑outs and production powers facilitate information flow for speedy decisions but risk mission creep: information disclosed for an application could be reused for other purposes unless regulations strictly limit use and retention.
Finally, many substantive implementation details are deferred to regulation (drug administration, leave authorities, member selection, reporting forms), so the statute’s real impact will be determined by regulatory content and funding decisions that are not included in the text itself.
There's more to this law than the bill.
Codify Laws traces every connection across the legislative lifecycle.